Adalimumab (Amjevita, Cyltezo, Hadlima) — 2026 Medicare Part D coverage
adalimumab — sold as Amjevita, Cyltezo, Hadlima, Humira, Hyrimoz, Simlandi, Yuflyma: 69 forms appear in Medicare Part D formularies for 2026. This page reports what plans filed with CMS; it does not recommend a plan.
Which plans in your county cover adalimumab?
Pick a county to see every Medicare Advantage plan filed there and every stand-alone Part D plan in its region, with this drug's tier, restrictions and tier cost sharing.
How to read drug coverage
Tier is the cost-sharing tier the plan assigned the drug in its CMS formulary filing; lower tiers usually cost less. PA = prior authorization, ST = step therapy (try another drug first), QL = quantity limit. Not on formulary means the plan did not list this exact form; the plan may cover another strength or a formulary exception may be possible. Cost sharing is the plan's initial-coverage amount for the tier as filed with CMS; the deductible, the $2,100 annual out-of-pocket cap, the $35 insulin cap and negotiated prices for selected drugs can change what you actually pay. Formularies change during the year; the plan's formulary document and Medicare.gov govern.
What the star rating under each Medicare Advantage plan means
What the star rating means. CMS rates every Medicare Advantage contract (the "H" number in the plan ID — all plans under it share the rating) on a 1-to-5 scale each October, from about 40 measures of care quality, member experience, complaints and appeals, customer service and, for plans with drug coverage, drug safety and pricing. The 2026 rating is largely based on performance measured in 2024.
5 Excellent4 Above average3 Average2 Below average1 Poor
Not rated means CMS published no overall rating — usually a contract too new to be measured or with too few members ("not enough data"); it is not a low score. A 5-star contract can be joined outside the normal enrollment windows (the 5-star Special Enrollment Period, Dec 8 – Nov 30). Medicare.gov flags contracts rated below 3 stars for three years running as low-performing. Stars describe the contract's past performance as CMS measured it; they are not a recommendation, and they do not tell you whether a plan's network, drugs or costs fit you.
Forms and strengths in 2026 formularies
| Form | Formularies listing it | Most common tier | PA | ST | QL |
|---|---|---|---|---|---|
| HADLIMA 40 MG in 0.4 ML Auto-Injector brand · RxCUI 2640432 | 250 (76%) | 5 | 247 | 0 | 190 |
| HADLIMA 40 MG in 0.4 ML Prefilled Syringe brand · RxCUI 2640428 | 250 (76%) | 5 | 247 | 0 | 190 |
| HADLIMA 40 MG in 0.8 ML Auto-Injector brand · RxCUI 2640300 | 250 (76%) | 5 | 247 | 0 | 190 |
| HADLIMA 40 MG in 0.8 ML Prefilled Syringe brand · RxCUI 2640305 | 250 (76%) | 5 | 247 | 0 | 190 |
| Humira 10 MG in 0.1 ML Prefilled Syringe brand · RxCUI 1921010 | 165 (50%) | 5 | 165 | 0 | 111 |
| Humira 20 MG in 0.2 ML Prefilled Syringe brand · RxCUI 1921017 | 164 (50%) | 5 | 164 | 0 | 111 |
| Humira 40 MG in 0.8 ML Auto-Injector brand · RxCUI 1655728 | 156 (48%) | 5 | 156 | 0 | 103 |
| Humira 80 MG in 0.8 mL Auto-Injector brand · RxCUI 1921240 | 156 (48%) | 5 | 156 | 0 | 103 |
| Humira Pen 80 MG/0.8 ML and 40 MG/0.4 ML - Psoriasis/Uveitis Starter Package (3 count) brand · RxCUI 1921468 | 156 (48%) | 5 | 156 | 0 | 98 |
| Humira 40 MG in 0.4 ML Auto-Injector brand · RxCUI 1872980 | 155 (47%) | 5 | 155 | 0 | 103 |
| Humira 40 MG in 0.4 ML Prefilled Syringe brand · RxCUI 1726846 | 155 (47%) | 5 | 155 | 0 | 103 |
| Humira 40 MG in 0.8 ML Prefilled Syringe brand · RxCUI 727705 | 155 (47%) | 5 | 155 | 0 | 103 |
| Humira Pen 80 MG/0.8 ML - Starter Package for Crohn's Disease, Ulcerative Colitis or Hidradenitis Suppurativa (3 count) brand · RxCUI 1921245 | 155 (47%) | 5 | 155 | 0 | 98 |
| Simlandi 20 MG in 0.2 ML Prefilled Syringe brand · RxCUI 2688823 | 145 (44%) | 5 | 142 | 0 | 136 |
| Simlandi 40 MG in 0.4 ML Auto-Injector brand · RxCUI 2677787 | 145 (44%) | 5 | 142 | 0 | 136 |
| Simlandi 40 MG in 0.4 ML Prefilled Syringe brand · RxCUI 2688827 | 145 (44%) | 5 | 142 | 0 | 136 |
| Simlandi 80 MG in 0.8 ML Auto-Injector brand · RxCUI 2706645 | 144 (44%) | 5 | 141 | 0 | 136 |
| adalimumab-aaty 80 MG in 0.8 ML Auto-Injector generic · RxCUI 2668487 | 90 (27%) | 5 | 89 | 0 | 36 |
| adalimumab-aaty Auto-Injector 80 MG/0.8 ML Starter Package for Crohn's Disease, Ulcerative Colitis or Hidradenitis Suppurativa (3 count) generic · RxCUI 2668489 | 90 (27%) | 5 | 89 | 0 | 34 |
| adalimumab-aaty 20 MG in 0.2 ML Prefilled Syringe generic · RxCUI 2668483 | 89 (27%) | 5 | 89 | 0 | 36 |
| adalimumab-aaty 40 MG in 0.4 ML Auto-Injector generic · RxCUI 2639651 | 89 (27%) | 5 | 89 | 0 | 36 |
| adalimumab-aaty 40 MG in 0.4 ML Prefilled Syringe generic · RxCUI 2639659 | 89 (27%) | 5 | 89 | 0 | 36 |
| Yuflyma 40 MG in 0.4 ML Auto-Injector brand · RxCUI 2639657 | 63 (19%) | 5 | 63 | 0 | 14 |
| Yuflyma 40 MG in 0.4 ML Prefilled Syringe brand · RxCUI 2639662 | 63 (19%) | 5 | 63 | 0 | 14 |
| Yuflyma 80 MG in 0.8 ML Auto-Injector brand · RxCUI 2668488 | 63 (19%) | 5 | 63 | 0 | 14 |
| Yuflyma Auto-Injector 80 MG/0.8 ML Starter Package for Crohn's Disease, Ulcerative Colitis or Hidradenitis Suppurativa (3 count) brand · RxCUI 2668490 | 63 (19%) | 5 | 63 | 0 | 14 |
| CYLTEZO 10 MG in 0.2 ML Prefilled Syringe brand · RxCUI 2640892 | 61 (19%) | 5 | 61 | 0 | 13 |
| CYLTEZO 20 MG in 0.4 ML Prefilled Syringe brand · RxCUI 2640894 | 61 (19%) | 5 | 61 | 0 | 13 |
| CYLTEZO 40 MG in 0.4 ML Auto-Injector brand · RxCUI 2680750 | 61 (19%) | 5 | 61 | 0 | 13 |
| CYLTEZO 40 MG in 0.4 ML Prefilled Syringe brand · RxCUI 2680746 | 61 (19%) | 5 | 61 | 0 | 13 |
| CYLTEZO 40 MG in 0.8 ML Auto-Injector brand · RxCUI 2640898 | 61 (19%) | 5 | 61 | 0 | 13 |
| CYLTEZO 40 MG in 0.8 ML Prefilled Syringe brand · RxCUI 2640889 | 61 (19%) | 5 | 61 | 0 | 13 |
| adalimumab-bwwd 40 MG in 0.4 ML Auto-Injector generic · RxCUI 2640430 | 59 (18%) | 5 | 59 | 0 | 59 |
| adalimumab-bwwd 40 MG in 0.4 ML Prefilled Syringe generic · RxCUI 2640425 | 59 (18%) | 5 | 59 | 0 | 59 |
| adalimumab-adbm 10 MG in 0.2 ML Prefilled Syringe generic · RxCUI 2640891 | 43 (13%) | 5 | 39 | 0 | 39 |
| adalimumab-adbm 20 MG in 0.4 ML Prefilled Syringe generic · RxCUI 2640893 | 43 (13%) | 5 | 39 | 0 | 39 |
| adalimumab-adbm 40 MG in 0.8 ML Auto-Injector generic · RxCUI 2640895 | 43 (13%) | 5 | 39 | 0 | 39 |
| adalimumab-adbm 40 MG in 0.8 ML Prefilled Syringe generic · RxCUI 2640883 | 43 (13%) | 5 | 39 | 0 | 39 |
| adalimumab-adbm 40 MG in 0.4 ML Auto-Injector generic · RxCUI 2680748 | 42 (13%) | 5 | 39 | 0 | 39 |
| adalimumab-adbm 40 MG in 0.4 ML Prefilled Syringe generic · RxCUI 2680743 | 42 (13%) | 5 | 39 | 0 | 39 |
| adalimumab-adaz 10 MG in 0.1 ML Prefilled Syringe generic · RxCUI 2641644 | 13 (4%) | 5 | 9 | 0 | 9 |
| adalimumab-adaz 20 MG in 0.2 ML Prefilled Syringe generic · RxCUI 2641653 | 13 (4%) | 5 | 9 | 0 | 9 |
| adalimumab-adaz 40 MG in 0.4 ML Auto-Injector generic · RxCUI 2641655 | 13 (4%) | 5 | 9 | 0 | 9 |
| adalimumab-adaz 40 MG in 0.4 ML Prefilled Syringe generic · RxCUI 2641660 | 13 (4%) | 5 | 9 | 0 | 9 |
| adalimumab-adaz 80 MG in 0.8 ML Auto-Injector generic · RxCUI 2641662 | 12 (4%) | 5 | 9 | 0 | 9 |
| adalimumab-fkjp 20 MG in 0.4 ML Prefilled Syringe generic · RxCUI 2640412 | 12 (4%) | 3 | 11 | 0 | 11 |
| adalimumab-fkjp 40 MG in 0.8 ML Auto-Injector generic · RxCUI 2640404 | 12 (4%) | 3 | 11 | 0 | 11 |
| adalimumab-fkjp 40 MG in 0.8 ML Prefilled Syringe generic · RxCUI 2640417 | 12 (4%) | 3 | 11 | 0 | 11 |
| AMJEVITA 20 MG in 0.2 ML Prefilled Syringe brand · RxCUI 2663904 | 6 (2%) | 5 | 4 | 0 | 3 |
| AMJEVITA 40 MG in 0.4 ML Auto-Injector brand · RxCUI 2663910 | 6 (2%) | 5 | 4 | 0 | 3 |
| AMJEVITA 40 MG in 0.4 ML Prefilled Syringe brand · RxCUI 2663907 | 6 (2%) | 5 | 4 | 0 | 3 |
| AMJEVITA 80 MG in 0.8 ML Auto-Injector brand · RxCUI 2663915 | 6 (2%) | 5 | 4 | 0 | 3 |
| AMJEVITA 10 MG in 0.2 ML Prefilled Syringe brand · RxCUI 2634479 | 4 (1%) | 5 | 2 | 0 | 1 |
| adalimumab-aacf 40 MG in 0.8 ML Auto-Injector generic · RxCUI 2640859 | 3 (1%) | 5 | 2 | 0 | 0 |
| adalimumab-ryvk 80 MG in 0.8 ML Auto-Injector generic · RxCUI 2706644 | 3 (1%) | 5 | 3 | 0 | 3 |
| adalimumab-aacf 40 MG in 0.8 ML Prefilled Syringe generic · RxCUI 2640851 | 2 (1%) | 3 | 2 | 0 | 0 |
| adalimumab-aacf starter pack 40 MG/0.8 ML Auto-Injector (4 count) generic · RxCUI 2640864 | 2 (1%) | 5 | 2 | 0 | 0 |
| adalimumab-aacf starter pack 40 MG/0.8 ML Auto-Injector (6 count) generic · RxCUI 2640869 | 2 (1%) | 5 | 2 | 0 | 0 |
| adalimumab-ryvk 40 MG in 0.4 ML Auto-Injector generic · RxCUI 2677780 | 2 (1%) | 5 | 2 | 0 | 2 |
| adalimumab-ryvk 40 MG in 0.4 ML Prefilled Syringe generic · RxCUI 2688826 | 2 (1%) | 5 | 2 | 0 | 2 |
| AMJEVITA 40 MG in 0.8 ML Auto-Injector brand · RxCUI 2627722 | 1 (0%) | 5 | 1 | 0 | 0 |
| AMJEVITA 40 MG in 0.8 ML Prefilled Syringe brand · RxCUI 2627725 | 1 (0%) | 5 | 1 | 0 | 0 |
| Hyrimoz 10 MG in 0.1 ML Prefilled Syringe brand · RxCUI 2641650 | 1 (0%) | 5 | 1 | 0 | 1 |
| Hyrimoz 20 MG in 0.2 ML Prefilled Syringe brand · RxCUI 2641654 | 1 (0%) | 5 | 1 | 0 | 1 |
| Hyrimoz 40 MG in 0.4 ML Auto-Injector brand · RxCUI 2641658 | 1 (0%) | 5 | 1 | 0 | 1 |
| Hyrimoz 40 MG in 0.4 ML Prefilled Syringe brand · RxCUI 2641661 | 1 (0%) | 5 | 1 | 0 | 1 |
| Hyrimoz 80 MG in 0.8 ML Auto-Injector brand · RxCUI 2641663 | 1 (0%) | 5 | 1 | 0 | 1 |
| Hyrimoz Crohn's and UC or Hidradenitis Suppurativa Starter Kit brand · RxCUI 2641665 | 1 (0%) | 5 | 1 | 0 | 1 |
| Hyrimoz Plaque Psoriasis or Uveitis Starter Kit brand · RxCUI 2641671 | 1 (0%) | 5 | 1 | 0 | 1 |
Counts are formularies (of 328) in the CMS file that list the form, and how many of those apply prior authorization (PA), step therapy (ST) or a quantity limit (QL). Many plans share one formulary, so plan counts in a county will differ.
How to read drug coverage
Tier is the cost-sharing tier the plan assigned the drug in its CMS formulary filing; lower tiers usually cost less. PA = prior authorization, ST = step therapy (try another drug first), QL = quantity limit. Not on formulary means the plan did not list this exact form; the plan may cover another strength or a formulary exception may be possible. Cost sharing is the plan's initial-coverage amount for the tier as filed with CMS; the deductible, the $2,100 annual out-of-pocket cap, the $35 insulin cap and negotiated prices for selected drugs can change what you actually pay. Formularies change during the year; the plan's formulary document and Medicare.gov govern.
What the star rating under each Medicare Advantage plan means
What the star rating means. CMS rates every Medicare Advantage contract (the "H" number in the plan ID — all plans under it share the rating) on a 1-to-5 scale each October, from about 40 measures of care quality, member experience, complaints and appeals, customer service and, for plans with drug coverage, drug safety and pricing. The 2026 rating is largely based on performance measured in 2024.
5 Excellent4 Above average3 Average2 Below average1 Poor
Not rated means CMS published no overall rating — usually a contract too new to be measured or with too few members ("not enough data"); it is not a low score. A 5-star contract can be joined outside the normal enrollment windows (the 5-star Special Enrollment Period, Dec 8 – Nov 30). Medicare.gov flags contracts rated below 3 stars for three years running as low-performing. Stars describe the contract's past performance as CMS measured it; they are not a recommendation, and they do not tell you whether a plan's network, drugs or costs fit you.